Lilly’s Covid-19 antibody helps patients rid their systems of virus sooner
Lilly, which is developing the drug with the biotechnology firm Abcellera, tested three doses of its antibody against placebo
Related Articles
The Venom Vanquisher – Scripps Research Magazine
Irene Khalek is on a quest to design a universal antivenom and protect people around the world from the deadliest snakebites. Across cultures, countries and mythologies,…
Scripps Research on Threads
June 2025 | 8 min 46 sec This year on Science Changing Life, we’ ve had some amazing scientists join us to share their work,…
Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV
A histological section of a lymph node showing a vaccine antigen (pink) localized within B cell follicles (blue), where B-cell activation is occurring, as indicated…
Calibr-Skaggs doses first patient with switchable CAR-T cell therapy in a phase 1 trial for metastatic breast cancer
CLBR001 + ABBV-461 is a novel, investigational, two-part, switchable chimeric antigen T cell (sCAR-T) immunotherapy designed to treat solid tumors. LA JOLLA, CA — The…
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
Eye image of a patient with macular telangiectasia type 2, showing tiny crystal-like deposits and abnormal blood vessels in the retina. Credit: Scripps Research Cell-based…
Diversifying the reference iPSC line concept
We discuss how to diversify the reference iPSC line concept. We highlight workflows for generating diverse iPSC lines. We ask whether reference lines can act…
Females may be more biochemically sensitive to alcohol—long before dependence sets in
Scripps Research’s insights into sex-based differences in brain chemistry could guide personalized treatment strategies for alcohol use disorder. LA JOLLA, CA — Alcohol affects everyone…
AI pinpoints new anti-aging drug candidates
More than 70% of the drugs identified by artificial intelligence extended the lifespan of C. elegans worms. LA JOLLA, CA — Everyone wants to slow…
Pete Schultz: On the future of science and medicine – Scripps Research Magazine
An interview with Pete Schultz, President and CEO of Scripps Research, on the next century of innovation Last year, Scripps Research celebrated its centennial and…
Diversifying the reference iPSC line concept
We discuss how to diversify the reference iPSC line concept. We highlight workflows for generating diverse iPSC lines. We ask whether reference lines can act…